ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8061 | Rec_0008071 | R14 |
RRRRRRRRRRRRRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Vibrio parahaemolyticus ISP 72-01 |
10-20 % | Growth inhibition assay at 10 μM |
24243601;26922474 | - |
YES |
| 8062 | Rec_0008072 | Unnamed |
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
not reported [other] |
- |
- |
- | - |
- | - |
NO |
| 8063 | Rec_0008073 | L-K6 |
IKKILSKIKKLLK |
synthetic construct [Synthetic] |
Antimicrobial |
B. cereus |
6.25 μM | MIC |
- | - |
YES |
| 8064 | Rec_0008074 | Gonadoliberin-1 |
QHWSYGLRPG |
Homo sapiens [Animal] |
Hormone, Endocrine, Reproductive regulator, Growth regulation, Development regulation, Receptor modulation |
- |
- | - |
6760865 | - |
NO |
| 8065 | Rec_0008075 | NLP-31 |
QWGYGGYGRGYGGYGGYGRGYGGYGGYGRGYGGYGRGMYGGYGRPYGGYGWGK |
Caenorhabditis elegans [Animal] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative, Antifungal |
- |
- | - |
15048112 | - |
NO |
| 8066 | Rec_0008076 | Glycoside hydrolase |
MVVRMILIILSVSLGYSGLAAQGGGEPPPDRLMIPASLFDRAVACIKSFEGWHYARHHPYIGYGHKLLPGEKLTCNLTKAQADSLLRADLIKRCSTFRRFGKDALILAVLSYNVGEYRLLGSGKIPKSTLIRKLESGNRDIYQEYISYCRYKGRRHAGLLKRRKTEFALFFIP |
Muribaculaceae bacterium Isolate-080 [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Hydrolase, Non-hemolytic, Non-ribosomal |
- |
- | - |
- | - |
NO |
| 8067 | Rec_0008077 | Unnamed |
KVEITNGGLTLMDVKN |
not reported [other] |
Immunomodulatory, Allergenicity |
- |
- | - |
37020337 | - |
NO |
| 8068 | Rec_0008078 | Sa-AFP1 |
KLCERPSGTWSGVCGNNNACKNQCINLEKARHGSCNYVFPAHKCICYFPC |
Salix alba [Plant] |
Antimicrobial, Antifungal |
- |
- | - |
- | - |
NO |
| 8069 | Rec_0008079 | Unnamed |
CDPPGDSCSRVYNDCCSNYCILRQSGPTC |
not reported [other] |
Toxin-related activity, Toxicity |
- |
- | - |
37020337 | - |
NO |
| 8070 | Rec_0008080 | hACE2(21-55)F28K-F32E |
IEEQAKTKLDKENHEAEDLFYQSSLASWNYNTNIT |
synthetic construct [Synthetic] |
Antiviral |
SARS-CoV-2 spike protein-hACE2 complex |
46.8 μM | IC50 |
33651072 | - |
YES |
| 8071 | Rec_0008081 | Lycosin-II |
VWLSALKFIGKHLAKHQLSKL |
Lycosa singoriensis [Animal] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative |
Escherichia coli ATCC 25922 |
1 μM | MIC |
34506798 | - |
YES |
| 8072 | Rec_0008082 | N-acetylmuramoyl-L-alanine amidase |
MNIKYITVHCSATKPSQKCNAEIMDGWHKSRGWSGLGYHFVILRDGELETGRPLNKQGAHVAGYNKDNVGVCLVGGVDENNKPVDNFTSKQMDALRYLITELAGNYGVKRQDIKGHRDWGVKKACPCFDVQERMRVWDD |
Vibrio phage 1.108.O._10N.222.51.A4 [Virus] |
Antimicrobial, Bacteriolytic enzyme, Non-hemolytic, Non-ribosomal |
- |
- | - |
- | - |
NO |
| 8073 | Rec_0008083 | Tu-AMP 2 |
KSCCPSTAARNCYNVCRFPG |
not reported [other] |
- |
Escherichia coli TOP10 |
4.27 OD_ID (dimensionless) | Mex pooled growth assay (OD_ID at 4.5 h) |
35260685 | - |
YES |
| 8074 | Rec_0008084 | Unnamed |
GVCRCICGRGVCRCICGR |
Pongo [Animal] |
Antiviral, Anti-HIV, Anti-HSV |
- |
- | - |
- | US 2009/0264344 A1 |
NO |
| 8075 | Rec_0008085 | Chaxapeptin |
GFGSKPLDSFGLNFF |
Streptomyces leeuwenhoekii [Bacterium] |
Antimicrobial, Antibacterial |
Staphylococcus aureus ATCC 25923 |
30-35 μg/mL | MIC |
26402731 | - |
YES |
| 8076 | Rec_0008086 | K10-K42 |
KGATYITYVNFLNELRVKTKPEGNSHGIPSLRK |
not reported [other] |
Antiviral, Replication inhibitor |
CEM-T4 |
- | Qualitative inhibition |
10195752 | - |
YES |
| 8077 | Rec_0008087 | LS-AMP-F1 |
TGLGKIGYLMKKLLSKAKV |
Lycosa sinensis [Animal] |
Antimicrobial |
Enterococcus faecium 2 clinical strains |
12.5 μM | MIC |
- | - |
YES |
| 8078 | Rec_0008088 | Pandinin 1 |
GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT |
Pandinus imperator [Animal] |
Antimicrobial, Antibacterial |
yeast C-albicans |
>20.8 μM | MIC |
- | - |
YES |
| 8079 | Rec_0008089 | Unnamed |
FAKKLAKLAK |
not reported [other] |
Anticancer |
- |
- | - |
- | - |
NO |
| 8080 | Rec_0008090 | Unnamed |
GQ |
not reported [other] |
Antihypertensive |
- |
- | - |
- | - |
NO |